Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gennium Pharmaceutique was a French specialty pharmaceutical company focused on the development and commercialization of generic injectable medicines for the hospital market. Founded in 2007 and headquartered in Saint-Cloud, France, the company specialized in therapeutic areas including anesthesia, analgesia, and emergency medicine. Gennium established a strong reputation for providing high-quality, value-added generic alternatives to complex injectable drugs used in surgical and intensive care settings. In July 2012, the company was acquired by Ethypharm, a global specialty pharmaceutical firm, to enhance Ethypharm's hospital product portfolio and market presence in France. Following the acquisition, Gennium's operations and product lines were integrated into Ethypharm's hospital division. The company played a significant role in the early growth of the hospital generics sector in Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gennium Pharmaceutique.